These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15451427)

  • 1. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions.
    Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J
    Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis.
    Schiopu A; Bengtsson J; Söderberg I; Janciauskiene S; Lindgren S; Ares MP; Shah PK; Carlsson R; Nilsson J; Fredrikson GN
    Circulation; 2004 Oct; 110(14):2047-52. PubMed ID: 15451805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.
    Gutierrez MM; Tsai SW; Phillips ML; Curtiss LK; Milne RW; Schumaker VN
    Biochemistry; 1999 Jan; 38(4):1284-92. PubMed ID: 9930989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
    Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
    J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences.
    Fredrikson GN; Söderberg I; Lindholm M; Dimayuga P; Chyu KY; Shah PK; Nilsson J
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):879-84. PubMed ID: 12649092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
    Radulescu L; Stancu C; Antohe F
    Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins.
    Hammer A; Kager G; Dohr G; Rabl H; Ghassempur I; Jürgens G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):704-13. PubMed ID: 7749884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oxidation on the structure and stability of human low-density lipoprotein.
    Jayaraman S; Gantz DL; Gursky O
    Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins.
    Malle E; Waeg G; Schreiber R; Gröne EF; Sattler W; Gröne HJ
    Eur J Biochem; 2000 Jul; 267(14):4495-503. PubMed ID: 10880973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL.
    Kato Y; Makino Y; Osawa T
    J Lipid Res; 1997 Jul; 38(7):1334-46. PubMed ID: 9254060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL.
    Kato Y; Tokunaga K; Osawa T
    Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody against oxidized lipoprotein recognizes foam cells in atherosclerotic lesions. Complex formation of oxidized phosphatidylcholines and polypeptides.
    Itabe H; Takeshima E; Iwasaki H; Kimura J; Yoshida Y; Imanaka T; Takano T
    J Biol Chem; 1994 May; 269(21):15274-9. PubMed ID: 8195164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of oxidized LDL on apolipoprotein AI and B synthesis in HepG2 cells.
    Bourdon E; Loreau N; Lagrost L; Davignon J; Bernier L; Blache D
    Free Radic Biol Med; 2006 Sep; 41(5):786-96. PubMed ID: 16895799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis.
    Wu JT; Wu LL
    Clin Lab Med; 1997 Sep; 17(3):595-604. PubMed ID: 9316776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a specific monoclonal antibody 9F5-3a and the development of assay system for oxidized HDL.
    Nakajima T; Sakagishi Y; Katahira T; Nagata A; Kuwae T; Nakamura H; Inoue I; Takahashi K; Katayama S; Komoda T
    Biochem Biophys Res Commun; 1995 Dec; 217(2):407-11. PubMed ID: 7503715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin cleavage of apolipoprotein Bh of rabbit LDL: structural comparisons with human apolipoprotein B-100.
    Leroy A; Castro G; Agnani G; Saïle R; Barkia A; Fruchart JC
    J Lipid Res; 1992 Jun; 33(6):889-98. PubMed ID: 1380972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde.
    Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK
    Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of LDL modified by myeloperoxidase in the penis in patients with vascular erectile dysfunction: a preliminary study.
    Zouaoui Boudjeltia K; Roumeguere T; Delree P; Moguilevsky N; Ducobu J; Vanhaeverbeek M; Wespes E
    Eur Urol; 2007 Jan; 51(1):262-8; discussion 268-9. PubMed ID: 17007997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-based immunoassay for evaluation of lipoprotein oxidation.
    Preobrazhensky S; Trakht I; Chestkov V; Wentz M
    Anal Biochem; 1995 May; 227(1):225-34. PubMed ID: 7545355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.